![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 5/10 | |
C12N 15/09 | |||
C12P 21/02 | |||
C07K 14/75 | |||
C07K 14/81 |
(11) | Number of the document | 3088513 |
(13) | Kind of document | T |
(96) | European patent application number | 14873182.1 |
Date of filing the European patent application | 2014-12-26 | |
(97) | Date of publication of the European application | 2016-11-02 |
(45) | Date of publication and mention of the grant of the patent | 2019-02-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2014/084516 |
Date | 2014-12-26 |
(87) | Number | WO 2015/099124 |
Date | 2015-07-02 |
(30) | Number | Date | Country code |
2013273145 | 2013-12-27 | JP |
(72) |
UNO, Shusei, JP
OTAKI, Momoko, JP
MURAKAMI, Kouji, JP
IDENO, Shoji, JP
|
(73) |
Japan Blood Products Organization,
4-1 Hamamatsucho 2-chome Minato-ku, Tokyo 105-6107,
JP
|
(54) | RECOMBINANT FIBRINOGEN HIGH-PRODUCTION LINE AND METHOD FOR PRODUCING SAME |
RECOMBINANT FIBRINOGEN HIGH-PRODUCTION LINE AND METHOD FOR PRODUCING SAME |